announcement, page-43

Epi and Aks - I too have enough in SLA now to make a substantial amount if things go well. And lets say these are our ground rout investments.

If things are confirmed and things do take off - I will be paying higher prices to substantially increase my holdings again. We are very close and these small clawbacks are just making my final entry that much cheaper =)


Barnsty SLA have the patented use of Ropren to treat the liver and have advanced trials over the past few years over their use to treat alzheimers and in normalising cholestorol. So I do not believe there is a risk we'll lose out on these two markets i.e. I believe once the final trials are complete SLA will move to get patents over those treatment areas too.

I am confident that although there is a risk that others could jump in and try steal the show .. it will take them years to get up to speed and conduct the necessary tests to generate a respectable product. Whereas the founder SLA will have a few years head start and may already be close to getting the patent. So its a risk for competitors as they may be wasting time/resources on trying to chase SLA's market .. and risking the chance that SLA will beat them to the patent office!

So there is a risk, but for cholestorol and alzheimers I think were pretty safe.

I think IF Ropren can help in other areas that have yet to have been discovered by SLA.. then we may lose out on those. Although we'd had a head start on anyone else who tries to get ahead of us due to all the research and studies already conducted.